Augmentace antidepresiv atypickými antipsychotiky v léčbě farmakorezistentní deprese

Warning

This publication doesn't include Faculty of Education. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.
Title in English Augmentation of antidepressants with atypical antipsychotics in the treatment of pharmacoresistant depression
Authors

ČEŠKOVÁ Eva

Year of publication 2011
Type Article in Periodical
Magazine / Source Česká a slovenská psychiatrie
MU Faculty or unit

Central European Institute of Technology

Citation
Field Psychiatry, sexuology
Keywords augmentation; antidepressants; atypical antipsychotics; risperidone; olanzapine; aripiprazol; quetiapine; quatiapine XR
Description Augmentation of antidepressants with atypical antipsychotics presents an often used strategy in the treatment of pharmacoresistant depression. This strategy is common in both out-patient and in-patient departments. Controlled studies were performed with risperidone, olanzapine, aripiprazol and quetiapine. Quetiapine XR it the first atypical antipsychotic in the Czech Republic proved as adjunctive treatment in depressive episodes non responding adequately to monotherapy with antidepressants.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.